Abatacept shows comparable efficacy to Humira in year two data in patients with moderate to severe rheumatoid arthritis
Bristol-Myers Squibb ( BMS ) has announced the results of year two data from AMPLE ( Abatacept Versus Adalimumab Comparison in Biologic-Naïve rheumatoid arthritis (RA) Subjects With Background Methotr ...
read article